tradingkey.logo
tradingkey.logo
検索

Smith & Nephew PLC

SNN
ウォッチリストに追加
30.290USD
+0.250+0.83%
終値 06/29, 16:00ET15分遅れの株価
12.81B時価総額
26.95直近12ヶ月PER

詳細情報 Smith & Nephew PLC 企業名

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. The Company's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.

Smith & Nephew PLCの企業情報

企業コードSNN
会社名Smith & Nephew PLC
上場日Sep 18, 2087
最高経営責任者「CEO」Nath (Deepak S)
従業員数17349
証券種類Depository Receipt
決算期末Sep 18
本社所在地Building 5
都市WATFORD
証券取引所NASDAQ OMX NASDAQ Basic NYSE
United Kingdom
郵便番号WD18 8YE
電話番号4401923477100
ウェブサイトhttps://www.smith-nephew.com/
企業コードSNN
上場日Sep 18, 2087
最高経営責任者「CEO」Nath (Deepak S)

Smith & Nephew PLCの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Chief Corporate Development & Strategy Officer
Chief Corporate Development & Strategy Officer
18.46K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
--
Mr. David King
Mr. David King
Non-Executive Independent Director
Non-Executive Independent Director
2.80K
--
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.41K
+2.16%
Mr. Paul Connolly
Mr. Paul Connolly
President - Global Operations
President - Global Operations
2.40K
+2.17%
Mr. John Ma
Mr. John Ma
Non-Executive Independent Director
Non-Executive Independent Director
1.37K
+22.23%
Mr. Mizanu Kebede
Mr. Mizanu Kebede
Chief Quality and Regulatory Affairs Officer
Chief Quality and Regulatory Affairs Officer
1.29K
+1.70%
Mr. Scott Schaffner
Mr. Scott Schaffner
President - Sports Medicine
President - Sports Medicine
1.19K
+4.86%
Mr. Craig Gaffin
Mr. Craig Gaffin
President - Orthopaedics
President - Orthopaedics
894.00
+2.57%
Ms. Elga Lohler
Ms. Elga Lohler
Chief Human Resources Officer
Chief Human Resources Officer
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Chief Corporate Development & Strategy Officer
Chief Corporate Development & Strategy Officer
18.46K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
--
Mr. David King
Mr. David King
Non-Executive Independent Director
Non-Executive Independent Director
2.80K
--
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.41K
+2.16%
Mr. Paul Connolly
Mr. Paul Connolly
President - Global Operations
President - Global Operations
2.40K
+2.17%
Mr. John Ma
Mr. John Ma
Non-Executive Independent Director
Non-Executive Independent Director
1.37K
+22.23%

よくある質問

Smith & Nephew PLCの上位5名の株主は誰ですか?

Smith & Nephew PLCの上位5名の株主は以下のとおりです。Dr. Ajay Dhankhar, Ph.D.

Smith & Nephew PLC(SNN)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Smith & Nephew PLCの株式を保有している機関は471社あり、保有株式の総市場価値は約30.95Mで、全体の7.25%を占めています。2025Q4と比較して、機関の持ち株は-11491314.00増加しています。

Smith & Nephew PLCの最大の収益源は何ですか?

2026Q1において、Sports Medicine Joint Repair部門がSmith & Nephew PLCにとって最大の収益を生み出しており、その金額は1.07Bで、全収益の17.31%を占めています。
KeyAI